Forty percent of patients with chronic rhinosinusitis (CRS) also have asthma, which places them in the subgroup of CRS patients resistant to all types of therapy. Functional endoscopic sinus surgery (FESS) has markedly improved as a treatment for CRS, but its effect on asthma is unclear. Sun Yat-Sen University conducted a study where it evaluated the long-term effect of FESS-oriented multimodal treatment for this subgroup.
Research & Publications
- COVID-19 Vaccine Boosters: What You Need to Know
- Untreated Hearing Loss Can Lead to Dementia and Falls
- The Magic of Music Therapy
- World Sinus Health Awareness Day: Why It’s Important to You!
- How Do I Prepare for a Doctor’s Appointment?
- How to Tell the Difference Between a Seasonal Allergy and COVID
- Dance Your Way to Better Balance
- You Could You Have a Deviated Nasal Septum and Not Realize It